Antibiotic | Community- acquired (N = 5) | Healthcare- related N = 24 | Hospital- acquired infection (N = 31) | Total |
---|---|---|---|---|
Amoxicillin-clavulanic acid | 3/5 | 21/24 | 31/31 | 55/60 |
Amikacin | 0/5 | 2/24 | 1/27 | 3/57 |
Cefepime | 5/5 | 24/24 | 31/31 | 60/60 |
Cefuroxime | 5/5 | 24/24 | 31/31 | 60/60 |
Cefotaxime | 5/5 | 24/24 | 31/31 | 60/60 |
Ceftazidime | 5/5 | 24/24 | 31/31 | 60/60 |
Ciprofloxacin | 3/5 | 21/24 | 31/31 | 55/60 |
Ertapenem | 0/5 | 0/24 | 0/31 | 0 / 60 |
Gentamicin | 1/5 | 13/24 | 14/31 | 28 /60 |
Imipenem | 0/5 | 0/24 | 0 /31 | 0 /60 |
Piperacillin/tazobactam | 2/5 | 12/24 | 20/31 | 34/60 |
Trimethoprim/sulfamethoxazole | 3/5 | 21/24 | 29/31 | 53/60 |